Clinical trial
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
NCT04893291 is registered in ClinicalTrials.gov with Fondazione Ricerca e Innovazione Cardiovascolare ETS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
- Lead sponsor
- Fondazione Ricerca e Innovazione Cardiovascolare ETS
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- November 16, 2021
- Completion date
- August 30, 2030
- Enrollment
- 1,820 (estimated)
- Sites
- 53
Conditions
As the registry lists them; a condition with its own page is linked.
coronary artery disease, coronary artery stenosis